A5218 | Relates to designating an individual to be notified in the case of dose or brand change for psychotropic medication | Smith & MosesA5218Assembly
Official Title
Relates to designating an individual to be notified in the case of dose or brand change for psychotropic medication
2023-2024 SessionWilliam A. BarclayAffects: Public Health Law Status
In Assembly Committee
Health
Impact Rating
Unable to calculate
Passage Likelihood
Unable to calculate